Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125800091 | 12580009 | 1 | I | 2016 | 20160712 | 20160721 | 20160721 | EXP | CA-SYMPLMED PHARMACEUTICALS-2016SYMPLMED000270 | SYMPLMED PHARMACEUTICALS | 0.00 | Y | 0.00000 | 20160721 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125800091 | 12580009 | 1 | PS | perindopril | PERINDOPRIL | 1 | Unknown | UNK | U | U | UNKNOWN | 20184 | TABLET | ||||||
125800091 | 12580009 | 2 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Intravenous (not otherwise specified) | 226 MG, UNK | U | U | UNKNOWN | 0 | 226 | MG | |||||
125800091 | 12580009 | 3 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Intravenous (not otherwise specified) | 241 MG, UNK | U | U | UNKNOWN | 0 | 241 | MG | |||||
125800091 | 12580009 | 4 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | U | U | UNKNOWN | 0 | ||||||||
125800091 | 12580009 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | UNK | U | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125800091 | 12580009 | 1 | Cardiac disorder |
125800091 | 12580009 | 2 | HER-2 positive breast cancer |
125800091 | 12580009 | 4 | HER-2 positive breast cancer |
125800091 | 12580009 | 5 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125800091 | 12580009 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125800091 | 12580009 | Abdominal discomfort | |
125800091 | 12580009 | Abdominal pain | |
125800091 | 12580009 | Asthenia | |
125800091 | 12580009 | Bronchitis | |
125800091 | 12580009 | Cancer pain | |
125800091 | 12580009 | Dacryostenosis acquired | |
125800091 | 12580009 | Diarrhoea | |
125800091 | 12580009 | Ear congestion | |
125800091 | 12580009 | Ear infection | |
125800091 | 12580009 | Fatigue | |
125800091 | 12580009 | Headache | |
125800091 | 12580009 | Heart rate decreased | |
125800091 | 12580009 | Hypotension | |
125800091 | 12580009 | Influenza like illness | |
125800091 | 12580009 | Malaise | |
125800091 | 12580009 | Nausea | |
125800091 | 12580009 | Oxygen saturation decreased | |
125800091 | 12580009 | Pain | |
125800091 | 12580009 | Paraesthesia | |
125800091 | 12580009 | Pharyngitis | |
125800091 | 12580009 | Sinusitis | |
125800091 | 12580009 | Viral infection | |
125800091 | 12580009 | Vision blurred | |
125800091 | 12580009 | Vomiting | |
125800091 | 12580009 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |